Korea Investment CORP Grows Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Korea Investment CORP grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 20.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 292,227 shares of the pharmacy operator's stock after buying an additional 49,300 shares during the quarter. Korea Investment CORP's holdings in Walgreens Boots Alliance were worth $2,726,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in WBA. Brooklyn Investment Group increased its holdings in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock valued at $44,000 after buying an additional 830 shares during the period. First Financial Corp IN raised its position in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after acquiring an additional 885 shares in the last quarter. CWA Asset Management Group LLC boosted its stake in Walgreens Boots Alliance by 9.2% in the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator's stock valued at $120,000 after acquiring an additional 1,084 shares in the last quarter. Metis Global Partners LLC boosted its position in shares of Walgreens Boots Alliance by 4.9% in the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock worth $222,000 after purchasing an additional 1,118 shares in the last quarter. Finally, Harbour Investments Inc. raised its stake in Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock valued at $265,000 after buying an additional 1,165 shares during the last quarter. Institutional investors own 58.59% of the company's stock.

Remove Ads

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA traded down $0.12 during trading hours on Thursday, reaching $11.06. The company had a trading volume of 22,718,139 shares, compared to its average volume of 20,802,564. The firm has a market cap of $9.56 billion, a PE ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $19.48. The business's 50 day moving average price is $10.79 and its 200-day moving average price is $9.95. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analysts' expectations of $37.40 billion. During the same quarter in the previous year, the company earned $0.66 earnings per share. The firm's revenue for the quarter was up 7.6% on a year-over-year basis. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on WBA shares. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. StockNews.com started coverage on Walgreens Boots Alliance in a research report on Thursday. They set a "hold" rating for the company. Finally, Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.